Stocktoria
SAB Biotherapeutics, Inc. SABS
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-01-12
SAB Biotherapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 2,749,087 | $10.7M | 4.48% |
| TWO SIGMA INVESTMENTS, LP | 214,632 | $837,065 | 0.35% |
| CITADEL ADVISORS LLC | 143,797 | $560,808 | 0.23% |
| RENAISSANCE TECHNOLOGIES LLC | 43,800 | $138,846 | 0.07% |
| BlackRock Finance, Inc. | 13,752 | $42,631 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.